Dysautonomia

Source: Wikipedia, the free encyclopedia.
Dysautonomia
Other namesAutonomic failure, Autonomic dysfunction
better source needed][4]
TreatmentSymptomatic and supportive[2]

Dysautonomia, autonomic failure, or autonomic dysfunction is a condition in which the

.

Diagnosis is made by functional testing of the ANS, focusing on the affected organ system. Investigations may be performed to identify underlying disease processes that may have led to the development of symptoms or autonomic neuropathy. Symptomatic treatment is available for many symptoms associated with dysautonomia, and some disease processes can be directly treated. Depending on the severity of the dysfunction, dysautonomia can range from being nearly symptomless and transient to disabling and/or life-threatening.[11]

Signs and symptoms

The symptoms of dysautonomia, which are numerous and vary widely for each person, are due to inefficient or unbalanced efferent signals sent via both systems.[medical citation needed] Symptoms in people with dysautonomia include:

Causes

Vincristine

Dysautonomia may be due to

neurologic diseases (primary dysautonomia)[5] or injury of the autonomic nervous system from an acquired disorder (secondary dysautonomia).[1][13]
Its most common causes include:

In the

chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis, raising the possibility that such dysautonomia could be their common clustering underlying pathogenesis.[27]

In addition to sometimes being a symptom of dysautonomia, anxiety can sometimes physically manifest symptoms resembling autonomic dysfunction.[28][29][30] A thorough investigation ruling out physiological causes is crucial, but in cases where relevant tests are performed and no causes are found or symptoms do not match any known disorders, a primary anxiety disorder is possible but should not be presumed.[31] For such patients, the anxiety sensitivity index may have better predictivity for anxiety disorders, while the Beck Anxiety Inventory may misleadingly suggest anxiety for patients with dysautonomia.[32]

Mitochondrial cytopathies can have autonomic dysfunction manifesting as orthostatic intolerance, sleep-related hypoventilation and arrhythmias.[10][33][34]

Mechanism

The autonomic nervous system is a component of the peripheral nervous system and comprises two branches: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PSNS). The SNS controls the more active responses, such as increasing heart rate and blood pressure. The PSNS slows down the heart rate and aids digestion, for example. Symptoms typically arise from abnormal responses of either the sympathetic or parasympathetic systems based on situation or environment.[5][35][25]

Diagnosis

Valsalva maneuver

Diagnosis of dysautonomia depends on the overall function of three autonomic functions—cardiovagal, adrenergic, and sudomotor. A diagnosis should at a minimum include measurements of blood pressure and heart rate while lying flat and after at least three minutes of standing. The best way to make a diagnosis includes a range of testing, notably an autonomic reflex screen, tilt table test, and testing of the sudomotor response (ESC, QSART or thermoregulatory sweat test).[36]

Additional tests and examinations to diagnose dysautonomia include:

Tests to elucidate the cause of dysautonomia can include:


Vegetative-vascular dystonia

Particularly in the Russian literature,

vegetative nervous system.[citation needed
]

A similar form of this disorder has been historically noticed in various wars, including the Crimean War and American Civil War, and among British troops who colonized India. This disorder was called "irritable heart syndrome" (Da Costa's syndrome) in 1871 by American physician Jacob DaCosta.[39]

Management

The H2 receptor antagonist cimetidine

Treatment of dysautonomia can be difficult; since it is made up of many different symptoms, a combination of drug therapies is often required to manage individual symptomatic complaints. In the case of autoimmune neuropathy, treatment with immunomodulatory therapies is done. If

acid reflux.[40]

To treat

scopolamine can be used. Intracutaneous injection of botulinum toxin type A can also be used in some cases.[41]

transvascular autonomic modulation, is specifically not approved in the United States to treat autonomic dysfunction.[42]

In contrast to orthostatic hypotension (OH) in which neurodegenerative diseases might underlie, postural orthostatic tachycardia syndrome (POTS) in which psychiatric diseases might underlie responds to psychiatric intervention/ medication, or shows spontaneous remission. [43][44]

Prognosis

The prognosis of dysautonomia depends on several factors; people with chronic, progressive, generalized dysautonomia in the setting of central nervous system degeneration such as Parkinson's disease or multiple system atrophy generally have poorer long-term prognoses. Dysautonomia can be fatal due to

gustatory sweating are more frequently identified in mortalities.[45]

See also

References

  1. ^ a b c d e f g h i j k l m "Autonomic Neuropathy Clinical Presentation: History, Physical, Causes". emedicine.medscape.com. Retrieved 2016-02-21.
  2. ^ a b "Dysautonomia Information Page | National Institute of Neurological Disorders and Stroke". www.ninds.nih.gov. Retrieved 2 January 2018.
  3. ^ "Dysautonomia | Autonomic Nervous System Disorders | MedlinePlus". NIH. Retrieved 2 January 2018.
  4. ^ . Patient info. Retrieved 2016-02-21.
  5. ^ a b c d e "Dysautonomia". NINDS. Archived from the original on 2016-12-02. Retrieved 2012-04-03.
  6. ^
    PMID 29508455
    .
  7. .
  8. .
  9. .
  10. ^ .
  11. .
  12. ^ a b c d e f g h i MedlinePlus Encyclopedia: Autonomic neuropathy
  13. PMID 22712762
    .
  14. .
  15. .
  16. .
  17. ^ "Dysautonomia: Malfunctions in Your Body's Automatic Functions".
  18. ^ "Dysautonomia in Sjögren's". 26 October 2023.
  19. PMID 24507822
    .
  20. .
  21. .
  22. .
  23. .
  24. ^ "Paraneoplastic syndromes of the nervous system". Mayo Clinic. Retrieved 13 September 2016.
  25. ^ a b c d Acob, Lori Mae Yvette. (2021). Autonomic Nervous System Dysfunction – Concussion Alliance. Retrieved 21 September 2021, from https://www.concussionalliance.org/autonomic-nervous-system-dysfunction
  26. S2CID 235628396
    .
  27. .
  28. ^ Soliman K, Sturman S, Sarkar PK, Michael A (2010). "Postural orthostatic tachycardia syndrome (POTS): a diagnostic dilemma". British Journal of Cardiology. 17 (1): 36–9.
  29. .
  30. .
  31. .
  32. .
  33. .
  34. .
  35. ^ "Autonomic Nervous System — National Library of Medicine". PubMed Health. National Center for Biotechnology Information. Retrieved 2016-02-21.
  36. ^
    PMID 22143168
    .
  37. .
  38. .
  39. ^ Halstead M (2018-01-01). "Postural Orthostatic Tachycardia Syndrome: An Analysis of Cross-Cultural Research, Historical Research, and Patient Narratives of the Diagnostic Experience". Senior Honors Theses & Projects.
  40. ^ "H2 Blockers. Reducing stomach acid with H2 Blockers. | Patient". Patient. Retrieved 2016-02-21.
  41. ^ "Diabetic Autonomic Neuropathy".
  42. ^ "Safety Alerts for Human Medical Products — Balloon angioplasty devices to treat autonomic dysfunction: FDA Safety Communication — FDA concern over experimental procedures". fda.gov. Retrieved 5 December 2020.
  43. PMID 38240001
    .
  44. .
  45. .

Further reading